
The BCL-XL TR-FRET Assay Kit is designed to measure the inhibition of BCLXL_x000D_binding to its ligand in a homogeneous 384 reaction format. This FRET-based assay_x000D_requires no time-consuming washing steps, making it especially suitable for high throughput_x000D_screening applications. The assay procedure is straightforward and simple; a sample containing_x000D_terbium-labeled donor, dye-labeled acceptor, BCL-XL, peptide ligand, and an inhibitor is_x000D_incubated for 120 minutes. Then, the fluorescence intensity is measured using a fluorescence_x000D_reader.

V roku 2007 získali Nobelovu cenu za fyziológiu alebo medicínu Mario R. Capecchi (USA), Sir Martin E...
Čítať viac
Trh s farmaceutickymi a biologickymi liekmi ponuka siroku skalu pripravkov urcenych na liecbu mnohyc...
Čítať viac
S oteplovanim pocasia rastie aj riziko prisatia kliestov. Tieto drobne pavukovce prenasaju mnoho roz...
Čítať viac